Organ
28 valuesReaders (Gemini 3.8 Flash, GPT-6 Luna)Jev checkAdjudicatorEntity mappingSearch
Field
organ on every row. Jev agrees with the published value on 99% of 647 rows. “Readers agree” compares the two readers before adjudication. Select a value for its rows, or a Jev answer for the rows where it differs.4. When EMA's text enumerates specific organs under a tumor-agnostic-style section (e.g. Keytruda MSI-H lists CRC, gastric, endometrial, etc.), emit one row per named organ — follow the text literally. Only use organ="tumor-agnostic" when the text explicitly says "solid tumours regardless of histology" or equivalent. Organ guidance for less obvious mappings:
- "pleural mesothelioma" / "peritoneal mesothelioma" → organ="mesothelium" (not "lung").
- "uveal melanoma" / "ocular melanoma" / "retinoblastoma" → organ="eye" (not "skin").
- "adrenocortical carcinoma" → organ="adrenal" (not "other").
- "thymic carcinoma" / "thymoma" → organ="thymus" (not "lung").
- "giant cell tumor of bone" / "osteosarcoma" / "chondrosarcoma" / "Ewing sarcoma" → organ="bone", histology=<subtype, e.g. "osteosarcoma">.
- "soft tissue sarcoma" / "leiomyosarcoma" / "liposarcoma" / "angiosarcoma" with no anatomic site → organ="soft-tissue", histology=<subtype>. Sarcoma is a histologic family, NEVER an organ.
- "uterine leiomyosarcoma" → organ="uterus", histology="leiomyosarcoma" (anatomic site wins over the sarcoma family).
- "GIST" / "gastrointestinal stromal tumor" → organ="stomach" (or the named GI site), histology="GIST".
- "tenosynovial giant cell tumor" → organ="soft-tissue", histology="tenosynovial giant cell tumor".
- "testicular germ cell tumour" → organ="testis", histology="germ cell tumor".
- "dermatofibrosarcoma protuberans" (DFSP) → organ="soft-tissue" (WHO classifies it with the soft tissue tumours).Anatomic site (WHO Blue Book organ) of the tumour in THIS ROW. Sarcoma is a histologic family, not an organ.
| Value | Definition (as Jev sees it) | Rows | Jev agrees | Jev answered instead |
|---|---|---|---|---|
lung | lung cancer incl. NSCLC, SCLC | 92 | 100% | – |
mesothelium | pleural or peritoneal mesothelioma | 3 | 100% | – |
thymus | thymoma, thymic carcinoma | 0 | – | – |
breast | breast cancer | 70 | 100% | – |
colorectal | colon, rectal, colorectal cancer | 21 | 100% | – |
stomach | gastric or gastro-oesophageal junction adenocarcinoma, GIST of stomach/GI tract | 19 | 100% | – |
esophagus | oesophageal cancer (squamous or adenocarcinoma of the oesophagus) | 11 | 100% | – |
pancreas | pancreatic cancer, pancreatic neuroendocrine tumours | 6 | 100% | – |
liver | hepatocellular carcinoma | 11 | 100% | – |
biliary | biliary tract cancer, cholangiocarcinoma, gallbladder cancer | 7 | 100% | – |
ovary | ovarian, fallopian tube, primary peritoneal cancer | 12 | 100% | – |
uterus | endometrial cancer, uterine sarcoma | 10 | 100% | – |
cervix | cervical cancer | 5 | 100% | – |
prostate | prostate cancer | 31 | 100% | – |
kidney | renal cell carcinoma | 26 | 100% | – |
bladder | urothelial carcinoma, bladder cancer | 20 | 100% | – |
testis | testicular germ cell tumour | 0 | – | – |
skin | cutaneous melanoma, basal cell carcinoma, cutaneous squamous cell carcinoma, Merkel cell | 27 | 100% | – |
eye | uveal/ocular melanoma, retinoblastoma | 1 | 100% | – |
CNS | glioma, glioblastoma, brain tumours | 12 | 100% | – |
thyroid | thyroid cancer | 9 | 100% | – |
adrenal | adrenocortical carcinoma, pheochromocytoma | 0 | – | – |
head-and-neck | head and neck squamous cell carcinoma, nasopharyngeal carcinoma | 10 | 100% | – |
bone | bone tumours: osteosarcoma, giant cell tumour of bone | 0 | – | – |
soft-tissue | soft tissue sarcoma without a named organ, tenosynovial giant cell tumour, dermatofibrosarcoma protuberans | 9 | 100% | – |
hematologic | leukaemia, lymphoma, myeloma, myelodysplastic and myeloproliferative neoplasms | 221 | 100% | |
tumor-agnostic | ONLY when the text says solid tumours regardless of histology/tumour type | 6 | 83% | |
other | none of the listed sites | 8 | 38% |